Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 3.09% | $19.20M | €338.67B | 41.66% | 76 Outperform | |
| AstraZeneca | 2.09% | $12.99M | £210.77B | 36.38% | 76 Outperform | |
| Roche Holding AG | 2.05% | $12.73M | CHF248.32B | 36.99% | 73 Outperform | |
| Nestlé SA | 1.93% | $12.04M | CHF200.72B | 13.21% | 71 Outperform | |
| SAP SE | 1.88% | $11.68M | €239.84B | -6.85% | 66 Neutral | |
| Novartis AG | 1.83% | $11.37M | CHF194.55B | 12.34% | 80 Outperform | |
| HSBC Holdings | 1.82% | $11.31M | £179.93B | 45.00% | 79 Outperform | |
| Shell (UK) | 1.64% | $10.19M | £160.28B | 9.52% | 77 Outperform | |
| Siemens | 1.45% | $9.03M | €171.21B | 20.92% | 74 Outperform | |
| LVMH Moet Hennessy Louis Vuitton | 1.34% | $8.31M | €303.03B | 5.65% | 78 Outperform |